Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome

  Free Subscription


15.07.2019

1 Acta Biomed
1 Chin J Integr Med
1 Curr Gastroenterol Rep
2 J Can Assoc Gastroenterol
1 J Gastroenterol Hepatol
1 Medicine (Baltimore)
1 Nat Med
1 Nat Rev Gastroenterol Hepatol
1 Neurogastroenterol Motil
4 Nihon Shokakibyo Gakkai Zasshi
1 Phytomedicine
1 Rev Epidemiol Sante Publique
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Biomed

  1. BONAVINA L, Arini A, Ficano L, Iannuzziello D, et al
    Abincol(R) (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.
    Acta Biomed. 2019;90.
    PubMed     Text format     Abstract available


    Chin J Integr Med

  2. TANG XD, Zhang SS, Hou XH, Li ZH, et al
    Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Chin J Integr Med. 2019 Jul 10. pii: 10.1007/s11655-019-3030.
    PubMed     Text format     Abstract available


    Curr Gastroenterol Rep

  3. IWASAKI M, Akiba Y, Kaunitz JD
    Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases.
    Curr Gastroenterol Rep. 2019;21:35.
    PubMed     Text format     Abstract available


    J Can Assoc Gastroenterol

  4. MOAYYEDI P, Marsiglio M, Andrews CN, Graff LA, et al
    Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same Data.
    J Can Assoc Gastroenterol. 2019;2:30-36.
    PubMed     Text format     Abstract available

  5. MOAYYEDI P, Andrews CN, MacQueen G, Korownyk C, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).
    J Can Assoc Gastroenterol. 2019;2:6-29.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  6. STASI C, Caserta A, Nisita C, Cortopassi S, et al
    The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment.
    J Gastroenterol Hepatol. 2019;34:713-719.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  7. LIANG D, Longgui N, Guoqiang X
    Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis.
    Medicine (Baltimore). 2019;98:e16068.
    PubMed     Text format     Abstract available


    Nat Med

  8. SUEZ J, Zmora N, Segal E, Elinav E, et al
    The pros, cons, and many unknowns of probiotics.
    Nat Med. 2019;25:716-729.
    PubMed     Text format     Abstract available


    Nat Rev Gastroenterol Hepatol

  9. DICKSON I
    Remotely delivered cognitive behavioural therapy superior to treatment as usual for IBS.
    Nat Rev Gastroenterol Hepatol. 2019;16:326.
    PubMed     Text format    


    Neurogastroenterol Motil

  10. TUCK CJ, Caminero A, Jimenez Vargas NN, Soltys CL, et al
    The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.
    Neurogastroenterol Motil. 2019 Jul 9:e13675. doi: 10.1111/nmo.13675.
    PubMed     Text format     Abstract available


    Nihon Shokakibyo Gakkai Zasshi

  11. FUKUDO S
    [Irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:543-551.
    PubMed     Text format    

  12. NOZU T, Okumura T
    [Mechanism of visceral hypersensitivity in patients with irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:552-559.
    PubMed     Text format    

  13. MISHIMA Y, Ishihara S
    [Role of mucosal inflammation in irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:560-569.
    PubMed     Text format    

  14. MASAOKA T, Kanai T
    [Current knowledge of irritable bowel syndrome -treatment].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:570-575.
    PubMed     Text format    


    Phytomedicine

  15. LI B, Rui J, Ding X, Chen Y, et al
    Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.
    Phytomedicine. 2019;63:152982.
    PubMed     Text format     Abstract available


    Rev Epidemiol Sante Publique

  16. SPILLEBOUT A, Dechelotte P, Ladner J, Tavolacci MP, et al
    Mental health among university students with eating disorders and irritable bowel syndrome in France.
    Rev Epidemiol Sante Publique. 2019 Jul 6. pii: S0398-7620(19)30433.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  17. ENCK P, Mazurak N
    [Microbiota and irritable bowel syndrome: A critical inventory].
    Z Gastroenterol. 2019;57:859-870.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: